Rebecca Previs
@BeccaPrevisMD
Followers
1K
Following
2K
Media
185
Statuses
724
Dir of Med Affairs at Labcorp Oncology; Gyn Onc; Duke adjunct. Pet mom to 🐶🐶🐱🦔🐭🐓🐝; passionate about pollination, gardening & piano. Opinions are mine.
Durham, NC
Joined March 2017
RT @VivekSubbiah: Comprehensive Genomic Profiling: A Required Tool for Precision Oncology @ASCO @ASCOPost @OncoAlert #ASCO23 @weoncologists….
0
23
0
RT @outcomes4me: One more week until our live Ask the Expert Q&A with @Labcorp's @BeccaPrevisMD! Join us to learn how #personalized #medici….
0
2
0
RT @CancerDocKo: Want to learn more about HER2-low breast cancer? Please tune into this webinar by my amazing colleague and oncologist, Dr.….
0
1
0
RT @ShannonWestin: 👏🙌NRG GY018!! We did it - improved progression free survival in MMRd AND MMRp #EndometrialCancer. Standard of care ==….
0
88
0
Check out @ElizabethABloom’s work today at #SGOMtg. She reports a molecular analysis of a retrospective cohort of patients with endometrial intraepithelial hyperplasia. 5% were dMMR; 4% were p53abn. @dukeobgyn #Previslab @KC_Strickland @pammiepeters @janicewon_ 🧪🔬👩🔬🧬
0
3
14
Mentoring is one of life’s greatest privileges—and it’s not about creating clones but giving the space for each to create themselves and their own authentic paths. Couldn’t be prouder of @pammiepeters and @ElizabethABloom. ⭐️ 👩🔬🔬🧬🧪#WomenInSTEM #sgomtg #PatientsPurposeProgress
2
0
31
Checkpoint inhibition has had limited efficacy in high grade epithelial cancer. So proud of @pammiepeters and her work evaluating MEM-288, a novel oncolytic adenovirus, demonstrating efficacy and generating a systemic immune response. #SGOMtg @dukeobgyn #PatientsPurposeProgress
0
5
15
RT @Brittdavidsonmd: Our fellow Pamela Peters discussing her work on MEM-288 under mentor @BeccaPrevisMD proud of her work to improve the u….
0
3
0
The data are in! Cryocompression therapy works during chemo and prevents subjective neuropathy in patients with gyn cancers. Congrats @MKMontesDeOca @LHavrilesky and @dukeobgyn team. #SGOMtg #PatientsPurposeProgress
0
7
17
Thank you @Stigetta and @womenofteal for being a voice and a light. We are grateful for your advocacy, leadership, and reminding us of our purpose. #SGOMtg #PatientsPurposeProgress
0
6
10
RT @TeamOvary_MSK: Standing room only for Dr. Britta Weigelt’s discussion of circulating tumor DNA! #SGO2023 @MSKPathology @SGO_org https:/….
0
4
0
0
0
1
Congrats to @DukeMedSchool’s @LindaM_Zambrano and her important work highlighting funding to lethality scores in patients with cancer. Despite its increase in mortality, #uterinecancer remains underfunded. This work informs policy change, advocacy and equitable funding. #sgomtg
1
6
16
Thanks to everyone who attended our @Labcorp Case Study presentation where we reviewed the clinical, morphologic, cytogenetic, and #molecular characteristics of a case with a TP53 biallelic alteration. #ASH22 @ASH_hematology
0
0
1
If you will be at the #ASH22 meeting next week, check out my @Labcorp teammate, @ESeversonMDPhD's presentation. 💜 the #ASHaiku! @ASH_hematology.
Getting ready for the #ASH22 meeting with my #ASHaiku:. ASH workshop with me.December 10th, New Orleans.Hemepath with @Labcorp . @ASH_hematology
0
0
2
We analyzed ClinicalTrials,gov and found <10% of trials enrolling patients with gyn cancers report racial/ethnicity. We need diversity+transparency in enrollment. @tomi_akinyemiju @MKMontesDeOca @BenPeipert @dukeobgyn @DukeCancer @Labcorp @ESeversonMDPhD.
0
4
2
RT @JNCCN: Healthcare Access Dimensions and Guideline-Concordant #OvarianCancer Treatment: SEER-Medicare Analysis of the ORCHiD Study: http….
0
7
0
Congrats @MKMontesDeOca and Dr. Tomi Akinyemiju!.
Study finds patient’s race affects ovarian cancer care. Read more: ↙️
0
0
1
RT @ESeversonMDPhD: We performed CGP on 3288 samples using @OmniSeqInsight’s NGS assay. We identified 16 NRG1 fusions – with an incidence o….
0
2
0
RT @ESeversonMDPhD: Check out poster #ST028 @AMPath today. @PGDx presents their validation study on plasma focus, an #NGS assay designed fo….
0
2
0